CN111896662A - 一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用 - Google Patents
一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用 Download PDFInfo
- Publication number
- CN111896662A CN111896662A CN202010328831.7A CN202010328831A CN111896662A CN 111896662 A CN111896662 A CN 111896662A CN 202010328831 A CN202010328831 A CN 202010328831A CN 111896662 A CN111896662 A CN 111896662A
- Authority
- CN
- China
- Prior art keywords
- chicken
- characteristic
- gly
- collagen peptide
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 71
- 102000008186 Collagen Human genes 0.000 title claims abstract description 64
- 108010035532 Collagen Proteins 0.000 title claims abstract description 64
- 229920001436 collagen Polymers 0.000 title claims abstract description 64
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 61
- 238000001514 detection method Methods 0.000 title claims abstract description 27
- 239000000047 product Substances 0.000 title claims abstract description 23
- 239000000413 hydrolysate Substances 0.000 title claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 235000004252 protein component Nutrition 0.000 claims abstract description 4
- 235000013330 chicken meat Nutrition 0.000 claims description 65
- 108010010803 Gelatin Proteins 0.000 claims description 44
- 229920000159 gelatin Polymers 0.000 claims description 44
- 235000019322 gelatine Nutrition 0.000 claims description 44
- 235000011852 gelatine desserts Nutrition 0.000 claims description 44
- 239000008273 gelatin Substances 0.000 claims description 43
- 150000002500 ions Chemical class 0.000 claims description 30
- 108020004999 messenger RNA Proteins 0.000 claims description 16
- 241000283690 Bos taurus Species 0.000 claims description 13
- 102000004142 Trypsin Human genes 0.000 claims description 12
- 108090000631 Trypsin Proteins 0.000 claims description 12
- 239000012588 trypsin Substances 0.000 claims description 12
- 241001465754 Metazoa Species 0.000 claims description 11
- 241001494479 Pecora Species 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 239000013558 reference substance Substances 0.000 claims description 8
- 238000001976 enzyme digestion Methods 0.000 claims description 7
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 claims description 6
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 claims description 6
- 210000000988 bone and bone Anatomy 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000282887 Suidae Species 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- BJBUEDPLEOHJGE-UHFFFAOYSA-N (2R,3S)-3-Hydroxy-2-pyrolidinecarboxylic acid Natural products OC1CCNC1C(O)=O BJBUEDPLEOHJGE-UHFFFAOYSA-N 0.000 claims description 2
- 229960002591 hydroxyproline Drugs 0.000 claims description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims description 2
- BJBUEDPLEOHJGE-IMJSIDKUSA-N trans-3-hydroxy-L-proline Chemical compound O[C@H]1CC[NH2+][C@@H]1C([O-])=O BJBUEDPLEOHJGE-IMJSIDKUSA-N 0.000 claims description 2
- 241000272517 Anseriformes Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 19
- 238000000034 method Methods 0.000 abstract description 8
- 108010019160 Pancreatin Proteins 0.000 abstract description 2
- 229940055695 pancreatin Drugs 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 241000282898 Sus scrofa Species 0.000 description 12
- 229920001184 polypeptide Polymers 0.000 description 12
- 238000001819 mass spectrum Methods 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 241000272525 Anas platyrhynchos Species 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 230000004481 post-translational protein modification Effects 0.000 description 4
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 3
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 3
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 3
- 239000001099 ammonium carbonate Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 241000272522 Anas Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102100033601 Collagen alpha-1(I) chain Human genes 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 108010029483 alpha 1 Chain Collagen Type I Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/14—Preparation by elimination of some components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8624—Detection of slopes or peaks; baseline correction
- G01N30/8631—Peaks
- G01N30/8634—Peak quality criteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/89—Inverse chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/067—Preparation by reaction, e.g. derivatising the sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/14—Preparation by elimination of some components
- G01N2030/146—Preparation by elimination of some components using membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8818—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Quality & Reliability (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用,属于检测技术领域。本发明涉及鸡源性成分的特征性胶原肽Asn‑Gly‑Leu‑Hyp‑Gly‑Pro‑Ile‑Gly‑Pro‑Ala‑Gly‑Val‑Arg,可通过检测该特征性胶原肽,来确定是否含有鸡源性成分。具体地,通过对样品中的蛋白成分进行胰酶酶切,使特征性胶原肽游离出来,然后通过液质联用仪检测是否含有该特征性胶原肽,来判定是否含有鸡源性成分。该方法具有特征性强,灵敏度高,操作简单,可对胶原水解物及其制品中的鸡源性成分进行测定。
Description
技术领域
本发明涉及一种鸡源性成分的特征性胶原肽及在胶原水解物和其制品检测中的应用,属于医药与食品检测领域。
背景技术
胶原在动物体内含量非常丰富,主要存在于在动物的骨、皮、筋和腱等结缔组织中。明胶是胶原的降解物,是由动物的骨、皮、筋和腱等为原料经适度水解而制得,具有优良的理化性能,广泛应用于食品、医药等诸多领域。明胶绝大部分是由猪牛和羊的皮或骨为原材料,但由于家禽和牲畜的疾病可能带来的安全风险、清真和宗教信仰不同,对明胶进行动物源性成分溯源具有重要意义。
明胶中主要成分为胶原蛋白多肽,可利用液质联用仪检测多肽来进行动物源性成分的溯源,然而由于多肽在同一物种中存在突变等现象,选定的多肽能否作为溯源的标记,关系到溯源的成功与否。而对鸡源性成分溯源的特征性胶原肽的选择,不但要克服基因突变带来的影响,而且还需在鸡中含有,而其他动物中不含有。选择鸡中不突变的特征性胶原肽,成为鸡源性成分溯源的关键。直接采用液质联用仪对样品进行检测分析,无法克服上述困难。从基因入手,分析寻找特征性胶原肽,是一条可行的路径。
发明内容
本发明针对上述问题,提供了一种从基因角度得到的鸡源性成分的特征性胶原肽及在胶原水解物和其制品中鸡源性成分的检测方法,该方法操作简单,特征性强,灵敏度高,可用于胶原水解物及其制品中鸡源性成分的溯源鉴定和含量测定。
本发明的技术方案如下:
一种鸡源性成分的特征性胶原肽及在胶原水解物和其制品检测中的应用,基于鸡的Ⅰ型胶原蛋白序列中包含特征性胶原肽,其氨基酸序列为Asn-Gly-Leu-Hyp-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg,其中Hyp为4羟基脯氨酸或3羟基脯氨酸。它是从牛、猪、羊、鸭与鸡中COL1A2蛋白的mRNA出发,找出鸡的稳定存在的特征mRNA序列,翻译成蛋白序列后利用液质联用技术检测,最终选定的特征性胶原肽。
该特征性胶原肽在胶原水解物及其制品检测中的应用,包括以下步骤:
(1)待检测样品用胰蛋白酶进行酶切,或提取待检测样品中的蛋白成分用胰蛋白酶进行酶切;待检测样品选自胶原水解物及其制品检测;
(2)放入液质联用仪,并以特征性胶原肽或含特征性胶原肽的胰蛋白酶酶切后的鸡明胶作为对照品,选择母离子m/z611.2及其子离子进行监测;如果检出该检测样品对应离子的保留时间与对照品一致,且检测样品对应其子离子与对照品的子离子一致,则所述待测样品含有鸡源性成分,鸡源性成分含量可由对照品与检测样品中的峰面积来计算;如果没有与对照品保留时间一致的该离子,则不含有鸡源性成分。
上述所述的胶原水解物包括明胶,明胶是由动物的骨和皮等为原料经水解所制得的明胶,胶原水解物制品是原料中含有明胶的食品、保健品或药品。
通过对样品中的蛋白成分进行胰酶酶切,使特征性胶原肽游离出来,然后通过液质联用仪检测是否含有该特征性胶原肽,来判定是否含有鸡源性成分。
采用本发明的方法,能够快速检测胶原水解物及其制品中是否含有鸡源性成分。尽管动物中存在基因突变导致蛋白序列差异,但本发明的特征性胶原肽的基因在鸡中保守性强,且为鸡特有,通过该特征性胶原肽,可对胶原水解物及其制品中鸡源性成分进行溯源检测。该方法具有特征性强,灵敏度高,操作简单,可对胶原水解物及其制品中的鸡源性成分进行测定。
附图说明
图1是鸡明胶中特征性胶原肽的子离子扫描质谱图(母离子m/z611.2,子离子扫描范围m/z200~1200);
图2是各种动物明胶SRM扫描模式下选择离子对m/z611.2→469.1,556.3监测的质谱图;
图3是以不同含量鸡明胶对应的特征性胶原肽的质谱检测峰面积(m/z611.2→469.1)的关系曲线图;
图4是鸡明胶及明胶制品(以QQ糖为例)在SRM扫描模式下选择离子对m/z611.2→469.1,556.3监测的质谱图。
图5是鸡、鸭、牛、猪、羊的COL1A2蛋白的部分mRNA序列及对应的比较。
具体实施方式
下面结合具体实施例来进一步描述本发明,本发明的优点和特点将会随着描述而更为清楚。但实施例仅是范例性的,并不对本发明的范围构成任何限制。本领域技术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明技术方案的细节和形式进行修改或替换,但这些修改和替换均落入本发明的保护范围内。
实施例1
1材料和试剂
材料:不同动物来源的明胶,分别来源于鸡、鸭、牛、猪、羊,分别从鸡皮、鸭皮、牛皮、猪皮、羊皮提取获得。
试剂:碳酸氢铵(分析纯)、胰蛋白酶(序列纯,购自中国药品生物制品检定研究院)。
2特征性胶原肽的筛选与确定
鸡的胶原产品主要是Ⅰ型胶原,包括COL1A1和COL1A2蛋白,并且具有一定的保守性,我们可以从COL1A2蛋白中筛选出一段肽作为鸡源性成分的特征性胶原肽。为了从基因中筛选出用于检测的稳定的特征性胶原肽,应满足以下条件:(a)与该段肽所对应mRNA序列相邻的三个碱基,翻译后应为精氨酸或赖氨酸,且该段肽所对应mRNA序列中第1~3个碱基,翻译后不应为脯氨酸;(b)该段肽所对应的mRNA序列中,碱基C、G的含量应大于60%;(c)该段肽上至少有一个氨基酸对应的mRNA符合以下任一条件:该氨基酸对应的密码子的三个碱基中,若第一个碱基为C或G,则相应地在鸭、牛、猪或羊中第一个碱基应为G或C;若第二个碱基为A或T,则相应地在鸭、牛、猪或羊中第二个碱基应为T或A;若第二个碱基为C或T,则相应地在鸭、牛、猪或羊中第二个碱基应为T或C;(d)利用质谱检测筛选出来的该段肽是否有翻译后修饰(即:是否有脯氨酸发生羟基化),如果没有翻译后修饰则筛选出来的该段肽即为鸡的特征性胶原肽;如果有翻译后修饰则翻译后修饰的多肽即为鸡的特征性胶原肽;(e)通过质谱检测应没有其他干扰信号。为此我们进行了如下实验:
(1)特征性胶原肽的初筛
将鸡、鸭、鹅、牛、猪、羊的COL1A2蛋白对应的mRNA序列进行比对,部分序列如图5所示(注:mRNA由细胞核内的DNA转录来的,有时候也用DNA链上的碱基顺序来表示mRNA上的序列)。图5线框中鸡的mRNA序列“AAT GGT CTC CCT GGA CCC ATT GGC CCT GCT GGT GTACGT”满足上述条件(a)、(b)、(c)。该序列翻译后,对应的多肽为“Asn-Gly-Leu-Pro-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg”,为确定多肽Asn-Gly-Leu-Pro-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg是否为鸡的特征性胶原肽,需进一步确定是否有翻译后修饰(即:是否有脯氨酸发生羟基化),因此进行了下一步的质谱检测试验来确定是否有翻译后修饰。
(2)特征性胶原肽的确定
a)取0.05g明胶样品于25ml量瓶中,加少量1%NH4HCO3溶液浸泡10min,60℃加热使其溶解,用1%NH4HCO3溶液稀释至刻度,摇匀,微孔滤膜过滤,精密量取续滤液0.2ml加入2mg/ml的胰蛋白酶溶液20μl,37℃恒温酶解12h。
b)取5μl的鸡明胶的酶解溶液放入液质联用仪检测多肽是否有羟基化修饰。液相条件:C18反相色谱柱(2.1mm×100mm,1.8μm),流动相A为0.1%甲酸溶液,流动相B为乙腈,流速0.3ml/min;梯度洗脱:0~25min,98%→80%流动相A,2%→20%流动相B。质谱条件:电喷雾正离子模式(ESI+),分别选择m/z564.1和m/z611.2为母离子进行子离子全扫描。结果:(1)以m/z603.2为母离子的子离子全扫描的质谱图与多肽Asn-Gly-Leu-Pro-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg不符;(2)以m/z611.2为母离子的子离子全扫描的质谱图,该离子为多肽Asn-Gly-Leu-Hyp-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg,见图1。结果表明鸡的mRNA序列“AAT GGT CTC CCT GGA CCC ATT GGC CCT GCT GGT GTA CGT”翻译的肽中有一个氨基酸被修饰了,即该多肽中有一个脯氨酸发生了羟基化,羟基化后的多肽序列为Asn-Gly-Leu-Hyp-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg。
c)取5μl酶解溶液放入液质联用仪检测。液相条件:C18反相色谱柱(2.1mm×100mm,1.8μm),流动相A为0.1%甲酸溶液,流动相B为乙腈,流速0.3ml/min;梯度洗脱:0~25min,98%→80%流动相A,2%→20%流动相B。质谱条件:电喷雾正离子模式(ESI+)选择进行SRM检测,选择m/z611.2→469.1,556.3作为检测离子对。结果见图2,21.7min处只有鸡明胶中检出相应的离子峰,其他均没有检出。
综上,多肽Asn-Gly-Leu-Hyp-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg可作为鸡源性成分的特征性胶原肽。
实施例2
1材料和试剂
材料:混合明胶样品(包括:含5%鸡明胶的猪明胶、10%鸡明胶的猪明胶、20%鸡明胶的猪明胶、40%鸡明胶的猪明胶、60%鸡明胶的猪明胶,纯鸡明胶)由实施例1中的明胶精确混合制成。
试剂:碳酸氢铵(分析纯)、胰蛋白酶(序列纯,购自中国药品生物制品检定研究院)。
2检测方法
(1)取0.05g明胶样品于25ml量瓶中,加少量1%NH4HCO3溶液浸泡10min,60℃加热使其溶解,用1%NH4HCO3溶液稀释至刻度,摇匀,微孔滤膜过滤,精密量取续滤液0.2ml加入2mg/ml的胰蛋白酶溶液20μl,37℃恒温酶解12h。
(2)取5μl酶解溶液放入液质联用仪检测。液相条件:C18反相色谱柱(2.1mm×100mm,1.8μm),流动相A为0.1%甲酸溶液,流动相B为乙腈,流速0.3ml/min;梯度洗脱:0~25min,98%→80%流动相A,2%→20%流动相B。质谱条件:电喷雾正离子模式(ESI+)选择进行SRM检测,选择m/z611.2→469.1,556.3作为检测离子对。
以鸡明胶的浓度为横坐标(X),以峰面积(m/z611.2→469.1)为纵坐标(Y),进行曲线绘制。结果见图3,标准曲线Y=1066050X-10524,线性相关系数R2=0.9974,线性良好。可见该法可用于鸡源性成分的含量检测。
实施例3
1材料和试剂
材料:鸡明胶、加入牛明胶的QQ糖(自制)、加入鸡明胶的QQ糖(自制);
试剂:碳酸氢铵(分析纯)、胰蛋白酶(序列纯,购自中国药品生物制品检定研究院)。
2检测方法
(1)取0.05~0.25g的鸡明胶、加入牛明胶的QQ糖、加入鸡明胶的QQ糖,分别置于25ml量瓶中,加少量1%NH4HCO3溶液浸泡10min,60℃加热使其溶解,用1%NH4HCO3溶液稀释至刻度,摇匀,微孔滤膜过滤,精密量取续滤液0.2ml加入2mg/ml的胰蛋白酶溶液20μl,37℃恒温酶解12h。
(2)取5μl酶解溶液放入液质联用仪检测。液相条件:C18反相色谱柱(2.1mm×100mm,1.8μm),流动相A为0.1%甲酸溶液,流动相B为乙腈,流速0.3ml/min;梯度洗脱:0~25min,98%→80%流动相A,2%→20%流动相B。质谱条件:电喷雾正离子模式(ESI+)选择进行SRM检测,选择m/z611.2→469.1,556.3作为检测离子对。
结果见图4,21.7min处鸡明胶和加入鸡明胶的QQ糖检出相应的离子峰,加入牛明胶的QQ糖没有检出,可见该法能够特异性检测明胶制品中的鸡源性成分。
Claims (5)
1.一种鸡源的特征性胶原肽,其特征在于,所述特征性胶原肽其氨基酸序列为Asn-Gly-Leu-Hyp-Gly-Pro-Ile-Gly-Pro-Ala-Gly-Val-Arg,其中Hyp为4羟基脯氨酸或3羟基脯氨酸。
2.按照权利要求1所述的一种鸡源的特征性胶原肽,其特征在于,所述特征性胶原肽是从牛、猪、羊、鸭与鸡中COL1A2蛋白的mRNA出发,找出鸡的稳定存在的特征mRNA序列,翻译成蛋白序列后利用液质联用技术检测,最终选定的特征性胶原肽。
3.按照权利要求1所述的一种鸡源的特征性胶原肽的应用,其特征在于,用于检测胶原水解物及其制品中是否含有鸡源性成分以及含量测定。
4.按照权利要求2所述的应用,其特征在于,具体包括以下步骤:
(1)待检测样品用胰蛋白酶进行酶切,或提取待检测样品中的蛋白成分用胰蛋白酶进行酶切;待检测样品选自胶原水解物及其制品检测;
(2)放入液质联用仪,并以特征性胶原肽或含特征性胶原肽的胰蛋白酶酶切后的鸡明胶作为对照品,选择母离子m/z611.2及其子离子进行监测;如果检出该检测样品对应离子的保留时间与对照品一致,且检测样品对应其子离子与对照品的子离子一致,则所述待测样品含有鸡源性成分,鸡源性成分含量可由对照品与检测样品中的峰面积来计算;如果没有与对照品保留时间一致的该离子,则不含有鸡源性成分。
5.按照权利要求4所述的应用,其特征在于,胶原水解物包括明胶,明胶是由动物的骨和皮等为原料经水解所制得的明胶,胶原水解物制品是原料中含有明胶的食品、保健品或药品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010328831.7A CN111896662A (zh) | 2020-04-23 | 2020-04-23 | 一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010328831.7A CN111896662A (zh) | 2020-04-23 | 2020-04-23 | 一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111896662A true CN111896662A (zh) | 2020-11-06 |
Family
ID=73206235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010328831.7A Pending CN111896662A (zh) | 2020-04-23 | 2020-04-23 | 一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111896662A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541295A (en) * | 1993-02-12 | 1996-07-30 | The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations | Detection of type II collagen and its peptides |
US20070154931A1 (en) * | 2005-12-15 | 2007-07-05 | Radich Jerald P | Genes associate with progression and response in chronic myeloid leukemia and uses thereof |
CN103383383A (zh) * | 2013-07-12 | 2013-11-06 | 山东东阿阿胶股份有限公司 | 一种胶类中药及其制品中猪源性成分的检测方法 |
-
2020
- 2020-04-23 CN CN202010328831.7A patent/CN111896662A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541295A (en) * | 1993-02-12 | 1996-07-30 | The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations | Detection of type II collagen and its peptides |
US20070154931A1 (en) * | 2005-12-15 | 2007-07-05 | Radich Jerald P | Genes associate with progression and response in chronic myeloid leukemia and uses thereof |
CN103383383A (zh) * | 2013-07-12 | 2013-11-06 | 山东东阿阿胶股份有限公司 | 一种胶类中药及其制品中猪源性成分的检测方法 |
Non-Patent Citations (7)
Title |
---|
MICHAEL BUCKLEY ET AL.: "A fossil protein chimera; difficulties in discriminating dinosaur peptide sequences from modern cross-contamination", 《PROC. R. SOC. B》 * |
MICHAEL BUCKLEY ET AL.: "A fossil protein chimera; difficulties in discriminating dinosaur peptide sequences from modern cross-contamination", 《PROC. R. SOC. B》, vol. 284, 31 May 2017 (2017-05-31), pages 1 - 8 * |
MICHAEL BUCKLEY等: "A fossil protein chimera; difficultie in discriminating dinosaur peptide sequences from modem cross-contamination", PROC. R. SOC., vol. 284, pages 1 - 8 * |
张晓梅 等: "利用高分辨质谱鉴定鱼胶原蛋白粉中的鱼源性成分", 《食品安全质量检测学报》 * |
张晓梅 等: "利用高分辨质谱鉴定鱼胶原蛋白粉中的鱼源性成分", 《食品安全质量检测学报》, no. 3, 25 March 2015 (2015-03-25), pages 906 - 913 * |
苏世伟 等: "食源性生物活性肽指纹图谱的含义与构建", 《食品工业科技》 * |
苏世伟 等: "食源性生物活性肽指纹图谱的含义与构建", 《食品工业科技》, no. 23, 1 December 2016 (2016-12-01), pages 396 - 399 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gu et al. | Identification of peptide biomarkers for authentication of Atlantic salmon and rainbow trout with untargeted and targeted proteomics approaches and quantitative detection of adulteration | |
Guo et al. | A rapid and simple UPLC-MS/MS method using collagen marker peptides for identification of porcine gelatin | |
CN113004374B (zh) | 鹿胶特征肽及鉴定待测样品中是否包含鹿胶的方法 | |
CN111443134A (zh) | 一种羊源性成分的标记肽及在明胶和明胶制品检测中的应用 | |
CN111239302B (zh) | 一种利用蛋白质内切酶切割胶原蛋白获得专属性肽段的方法和应用 | |
CN111766323B (zh) | 一种用于检测骆驼奶中掺入牛奶的特征肽组合及方法 | |
Cai et al. | A quantitative strategy of ultrasound-assisted digestion combined UPLC-MS/MS for rapid identifying species-specific peptide markers in the application of food gelatin authentication | |
Zhu et al. | Determination of porcine derived components in gelatin and gelatin-containing foods by high performance liquid chromatography-tandem mass spectrometry | |
CN116462749A (zh) | 促肝细胞生长素特征多肽组及其应用 | |
Guo et al. | Marker peptide combination for source identification of gelatins obtained from Equidae hides by LC–MS/MS detection | |
CN111896663B (zh) | 鸡源的特征性ⅲ型胶原肽及在胶原水解物和其制品检测中的应用 | |
CN111896664B (zh) | 一种金枪鱼特征胶原肽及在胶原水解物和其制品鉴定中的应用 | |
CN111766324A (zh) | 一种用于检测水牛奶中掺入牛奶的特征肽组合及方法 | |
Deng et al. | Authentication of chicken-derived components in collagen-containing foods using natural macromolecular marker fragments by LC-MS method | |
CN111735891A (zh) | 家禽源的特征性胶原肽及在胶原水解物和其制品检测中的应用 | |
CN111751476B (zh) | 一种鸭源的特征性ⅲ型胶原肽及在胶原水解物和其制品检测中的应用 | |
CN114720601B (zh) | 三条特征性肽段及其应用 | |
CN111896662A (zh) | 一种鸡源的特征性胶原肽及在胶原水解物和其制品检测中的应用 | |
CN111060622B (zh) | 一种金枪鱼源性成分的标记肽及在胶原降解物和其制品检测中的应用 | |
Tai et al. | Non-targeted identification of D-amino acid-containing peptides through enzymatic screening, chiral amino acid analysis, and LC-MS | |
CN113429474B (zh) | 一种基于特征性肽段标签鉴别植物蛋白肉样品掺假情况的方法 | |
Yang et al. | Identification of five gelatins based on marker peptides from type i collagen by mass spectrum in multiple reaction monitoring mode | |
CN111122755B (zh) | 从可食用肉中检测非可食用肉的特征多肽及方法 | |
CN111122756B (zh) | 检测可食用肉的特征多肽及方法 | |
Yussif et al. | Evaluation of endogenous peptide stereochemistry using liquid chromatography-mass spectrometry-based spiking experiments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201106 |